Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Cancer risk associated with simian virus 40 contaminated polio vaccine.
Fisher SG, Weber L, Carbone M.
Anticancer Res. 1999 May-Jun;19(3B):2173-80.
Similar articles
Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin's lymphoma.
Rizzo P, Carbone M, Fisher SG, Matker C, Swinnen LJ, Powers A, Di Resta I, Alkan S, Pass HI, Fisher RI.
Chest. 1999 Dec;116(6 Suppl):470S-473S.
New molecular and epidemiological issues in mesothelioma: role of SV40.
Carbone M, Fisher S, Powers A, Pass HI, Rizzo P.
J Cell Physiol. 1999 Aug;180(2):167-72. Review.
Oncogene alterations in primary, recurrent, and metastatic human bone tumors.
Pompetti F, Rizzo P, Simon RM, Freidlin B, Mew DJ, Pass HI, Picci P, Levine AS, Carbone M.
J Cell Biochem. 1996 Oct;63(1):37-50. Review.
Simian virus 40: the link with human malignant mesothelioma is well established.
Carbone M, Rizzo P, Pass H.
Anticancer Res. 2000 Mar-Apr;20(2A):875-7.
SV40 as an oncogenic virus and possible human pathogen.
Weiss R, Giordano A, Furth P, DeCaprio J, Pipas J, Ozer H, Strickler H, Procopio A, Garcea R, Carbone M.
Dev Biol Stand. 1998;94:355-60, 369-82. Review. No abstract available.
Simian virus 40, poliovaccines and human tumors: a review of recent developments.
Carbone M, Rizzo P, Pass HI.
Oncogene. 1997 Oct 16;15(16):1877-88. Review.
Simian virus 40 and human tumors: It is time to study mechanisms.
Carbone M.
J Cell Biochem. 1999 Dec;76(2):189-93. Review.
Simian virus 40 oncogenesis in hamsters.
Carbone M, Stach R, Di Resta I, Pass HI, Rizzo P.
Dev Biol Stand. 1998;94:273-9.
Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961.
Cutrone R, Lednicky J, Dunn G, Rizzo P, Bocchetta M, Chumakov K, Minor P, Carbone M.
Cancer Res. 2005 Nov 15;65(22):10273-9.
SV40 and Notch-I: multi-functionality meets pleiotropy.
Carbone M, Bocchetta M.
Prog Mol Subcell Biol. 2004;36:289-305. Review. No abstract available.
Development of malignant mesothelioma during treatment for prolymphocytic leukemia: is asbestos or simian virus 40 a link?
Tanvetyanon T, Elmishad AG, Carbone M.
Anticancer Res. 2005 Jan-Feb;25(1B):429-33.
Environmental risk of mesothelioma in the United States: An emerging concern-epidemiological issues.
Baumann F, Carbone M.
J Toxicol Environ Health B Crit Rev. 2016;19(5-6):231-249.
Unique strains of SV40 in commercial poliovaccines from 1955 not readily identifiable with current testing for SV40 infection.
Rizzo P, Di Resta I, Powers A, Ratner H, Carbone M.
Cancer Res. 1999 Dec 15;59(24):6103-8.
Polio vaccines, SV40 and human tumours, an update on false positive and false negative results.
Elmishad AG, Bocchetta M, Pass HI, Carbone M.
Dev Biol (Basel). 2006;123:109-17; discussion 119-32.
The biological activities of simian virus 40 large-T antigen and its possible oncogenic effects in humans.
Matker CM, Rizzo P, Pass HI, Di Resta I, Powers A, Mutti L, Kast WM, Carbone M.
Monaldi Arch Chest Dis. 1998 Apr;53(2):193-7. Review.
Human T cell responses to endogenously presented HLA-A*0201 restricted peptides of Simian virus 40 large T antigen.
Velders MP, Macedo MF, Provenzano M, Elmishad AG, Holzhütter HG, Carbone M, Kast WM.
J Cell Biochem. 2001 Apr 2-27;82(1):155-62.
The detection of simian virus 40 in human tumors by polymerase chain reaction.
Rizzo P, Di Resta I, Powers A, Matker CM, Zhang A, Mutti L, Kast WM, Pass H, Carbone M.
Monaldi Arch Chest Dis. 1998 Apr;53(2):202-10. Review.
The relationship between simian virus 40 and mesothelioma.
Rivera Z, Strianese O, Bertino P, Yang H, Pass H, Carbone M.
Curr Opin Pulm Med. 2008 Jul;14(4):316-21. doi: 10.1097/MCP.0b013e3283018220. Review.
New developments about the association of SV40 with human mesothelioma.
Carbone M, Pass HI, Miele L, Bocchetta M.
Oncogene. 2003 Aug 11;22(33):5173-80. Review.
Filters: Manage Filters